Bibliography
- Garbe C. & Orfanos C. E. Epidemiology of malignant melanoma in Central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res, 1992, (suppl. 2) : 285-294.
- Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin- dependant kinase-4 inhibitors gene in multiple human cancers. Nature, 1994, 368: 753-756.
- Walker G. J., Palmer J. M., Walters M. K., Hayward N. K. A genetic model of melanoma tumorogenesis based on allelic losses. Genes Chromosom Cancer, 1995, 12: 134-141.
- Heenen M. Le cycle cellulaire : sa régulation et ses anomalies dans les tumeurs épidermiques. Ann Dermatol Venereol, 1997, 124: 452-456.
- Wang Y. L., Uhara H., Yamazaki Y., Nikaido T., Saida T. Immunohistochemical detection of CDK4 and p 16 proteins in cutaneous malignant melanoma. Br J Dermatol, 1996, 134: 269-275.
- Williams G. T., Smith C. A. Molecular regulation of apoptosis: genetic control on cell death. Cell, 1993, 74: 777-779.
- Verhaegh M. E. J. M., Sanders C. J. G., Arends J. W., Neuwmann H. A. M. Expression of the apoptosis — suppressing protein be 12 in non-melanoma skin cancer. Br J Dermatol, 1995, 132: 740-744.
- Mac Kie R. M. Diagnosis and differential diagnosis, In: Champion R. H., Burton J. L., Ebling F. J. G. eds. Textbook of Dermatology. Melanocytic naevi and malignant melanoma. Oxford Blackwell Scientific Publications, Rook-Wilkinson-Ebling, 1992, 1554-1555.